Bajpai, R
Matulis, S M
Wei, C
Nooka, A K
Von Hollen, H E
Lonial, S
Boise, L H
Shanmugam, M
Article History
Received: 17 August 2015
Revised: 9 October 2015
Accepted: 30 October 2015
First Online: 7 December 2015
Competing interests
: LHB is a consultant for Onyx Pharmaceuticals and Novartis; AKN is consultant for Onyx Pharmaceuticals and Spectrum pharmaceuticals; SL is a consultant for Millennium, Onyx Pharmaceuticals, Novartis, BMS, Janssen and Celgene. The remaining authors declare no conflict of interest.